Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

BACKGROUND: Lymphomas comprise a heterogeneous group of malignant diseases with highly variable prognosis. Rheumatoid arthritis (RA) is associated with a twofold increased risk of both Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL). It is unknown whether treatment with biologic disease-mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Mercer, Louise K, Regierer, Anne C, Mariette, Xavier, Dixon, William G, Baecklund, Eva, Hellgren, Karin, Dreyer, Lene, Hetland, Merete Lund, Cordtz, René, Hyrich, Kimme, Strangfeld, Anja, Zink, Angela, Canhao, Helena, Hernandez, M Victoria, Tubach, Florence, Gottenberg, Jacques-Eric, Morel, Jacques, Zavada, Jakub, Iannone, Florenzo, Askling, Johan, Listing, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705847/
https://www.ncbi.nlm.nih.gov/pubmed/28822981
http://dx.doi.org/10.1136/annrheumdis-2017-211623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705847/
https://www.ncbi.nlm.nih.gov/pubmed/28822981
http://dx.doi.org/10.1136/annrheumdis-2017-211623

Ejemplares similares